𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Specificity of regulatory CD4+CD25+ T cells for self-T cell receptor determinants

✍ Scribed by Abigail C. Buenafe; Laura Tsaknaridis; Leslie Spencer; Kevin S. Hicks; Rachel H. McMahan; Lisa Watson; Nicole E. Culbertson; Dorian Latocha; Keith Wegmann; Tom Finn; Richard Bartholomew; Gregory G. Burrows; Ruth Whitham; Dennis N. Bourdette; Richard E. Jones; Halina Offner; Yuan K. Chou; Arthur A. Vandenbark


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
445 KB
Volume
76
Category
Article
ISSN
0360-4012

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Although the phenotypic and regulatory properties of the CD4^+^CD25^+^ T cell lineage (Treg cells) have been well described, the specificities remain largely unknown. We demonstrate here that the CD4^+^CD25^+^ Treg population includes the recognition of a broad spectrum of human TCR CDR2 determinants found in the germline V gene repertoire as well as that of a clonotypic nongermline‐encoded CDR3β sequence present in a recombinant soluble T cell receptor (TCR) protein. Regulatory activity was demonstrated in T cell lines responsive to TCR but not in T cell lines responsive to control antigens. Inhibitory activity of TCR‐reactive T cells required cell–cell contact and involved CTLA‐4, GITR, IL‐10, and IL‐17. Thus, the T–T regulatory network includes Treg cells with specificity directed toward self‐TCR determinants. © 2004 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Ex vivo expansion of CD4+CD25+ T regulat
✍ Piotr Trzonkowski; Magdalena Szaryńska; Jolanta Myśliwska; Andrzej Myśliwski 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB

## Abstract Immunosuppressants are powerful drugs, capable of triggering severe adverse effects. Hence, there is tremendous interest in replacing them with less‐toxic agents. Adoptive therapy with CD25^+^CD4^+^ T regulatory cells (Tregs) holds promise as an alternative to immunosuppressants. Tregs